Ycg LLC raised its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 0.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 114,420 shares of the company’s stock after buying an additional 92 shares during the period. Procter & Gamble comprises about 1.5% of Ycg LLC’s portfolio, making the stock its 25th largest holding. Ycg LLC’s holdings in Procter & Gamble were worth $18,870,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Transcendent Capital Group LLC purchased a new position in Procter & Gamble in the 4th quarter worth approximately $31,000. Ruedi Wealth Management Inc. increased its stake in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares during the last quarter. POM Investment Strategies LLC purchased a new stake in Procter & Gamble in the second quarter valued at $34,000. Vima LLC acquired a new position in shares of Procter & Gamble in the 4th quarter valued at $35,000. Finally, Redmont Wealth Advisors LLC purchased a new stake in Procter & Gamble in the 1st quarter valued at about $42,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Insider Buying and Selling
In other news, CEO R. Alexandra Keith sold 3,373 shares of Procter & Gamble stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $170.00, for a total transaction of $573,410.00. Following the completion of the sale, the chief executive officer now directly owns 21,513 shares in the company, valued at $3,657,210. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO R. Alexandra Keith sold 3,373 shares of the company’s stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $170.00, for a total transaction of $573,410.00. Following the transaction, the chief executive officer now directly owns 21,513 shares of the company’s stock, valued at approximately $3,657,210. The disclosure for this sale can be found here. Insiders sold 375,553 shares of company stock worth $63,829,141 in the last ninety days. Insiders own 0.17% of the company’s stock.
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. During the same quarter in the prior year, the company posted $1.37 earnings per share. Procter & Gamble’s quarterly revenue was down .1% on a year-over-year basis. On average, equities analysts forecast that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were paid a $1.0065 dividend. The ex-dividend date was Friday, July 19th. This represents a $4.03 dividend on an annualized basis and a yield of 2.29%. Procter & Gamble’s payout ratio is 65.69%.
Analysts Set New Price Targets
Several equities analysts have recently commented on the stock. Evercore ISI upped their price objective on shares of Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a report on Thursday, July 18th. DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective on the stock in a report on Thursday, August 29th. JPMorgan Chase & Co. decreased their price target on shares of Procter & Gamble from $181.00 to $179.00 and set an “overweight” rating for the company in a research report on Wednesday, July 31st. TD Cowen began coverage on Procter & Gamble in a report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price target on the stock. Finally, Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Eight equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus target price of $175.79.
View Our Latest Stock Report on Procter & Gamble
Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
See Also
- Five stocks we like better than Procter & Gamble
- How to Calculate Options Profits
- GE Vernova’s Rally Could Continue as Wind Business Gains Ground
- Canada Bond Market Holiday: How to Invest and Trade
- DraftKings vs. DoubleDown: Growth in the Online Gambling Boom
- Top Biotech Stocks: Exploring Innovation Opportunities
- Join UiPath’s AI Surge and Catch the Coming Stock Price Reversal
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.